Bupropion (Wellbutrin) is not recommended as first-line treatment for adjustment disorder with depressed mood, as it is FDA-approved only for major depressive disorder (MDD) and seasonal affective disorder (SAD), not for adjustment disorders.
FDA-Approved Indications
Bupropion is FDA-approved exclusively for:
- Major depressive disorder (MDD) 1
- Seasonal affective disorder (SAD) 1
- Smoking cessation (as Zyban formulation)
The FDA label explicitly states that bupropion's efficacy was established in controlled trials of patients meeting DSM criteria for MDD, not adjustment disorders 1.
Key Clinical Distinction
Adjustment disorder with depressed mood differs fundamentally from MDD:
- Adjustment disorder is a stress-related condition triggered by identifiable psychosocial stressors
- Symptoms are typically less severe and time-limited (usually resolving within 6 months after stressor removal)
- MDD requires more pervasive symptoms meeting specific DSM criteria for duration and severity
The evidence base for bupropion exists only for MDD, where it demonstrates efficacy comparable to SSRIs 2, 3, 4. No studies have evaluated bupropion specifically for adjustment disorders.
Treatment Approach for Adjustment Disorder with Depressed Mood
First-line treatment should be:
- Psychotherapy - particularly problem-solving therapy, brief supportive therapy, or cognitive-behavioral approaches targeting the specific stressor
- Watchful waiting with supportive interventions, as many cases resolve spontaneously once the stressor is removed or adaptation occurs
Consider pharmacotherapy only if:
- Symptoms are severe and significantly impairing function
- Psychotherapy alone is insufficient after 4-6 weeks
- The clinical picture evolves to meet full criteria for MDD
If Antidepressant Treatment Becomes Necessary
If the severity warrants medication (suggesting possible evolution to MDD):
The 2008 American College of Physicians guideline recommends selecting between cognitive behavioral therapy or second-generation antidepressants after discussing effects, adverse events, cost, and patient preferences 4. Among second-generation antidepressants, SSRIs are typically preferred as first-line agents due to:
- Broader evidence base
- Better tolerability profile in most patients
- Lower seizure risk compared to bupropion
Bupropion may be considered as an alternative if:
- Patient has prominent fatigue, low energy, or decreased motivation (bupropion shows efficacy for these symptoms in MDD) 5
- Sexual dysfunction is a concern (bupropion has significantly lower rates than SSRIs) 2
- Patient is also attempting smoking cessation 6
- Patient has comorbid obesity and depressed mood (naltrexone-bupropion combination may be reasonable) 7
Critical Safety Considerations
Before prescribing bupropion, screen for contraindications:
- Seizure history or risk factors (stroke, brain metastases, eating disorders) - absolute contraindication 6, 1
- Current or recent (within 14 days) MAOI use 1
- Uncontrolled hypertension 7
- Bulimia or anorexia nervosa (higher seizure incidence) 8
Monitor closely for:
- Suicidal thoughts and behaviors, especially in patients under age 24 1
- Neuropsychiatric symptoms including anxiety, agitation, or mood destabilization 6, 9
- Seizures (dose-dependent risk; maximum 450 mg/day immediate-release, 400 mg/day sustained-release) 1
Dosing If Prescribed
Standard bupropion XL dosing for depression:
- Start: 150 mg once daily in the morning 1
- After 4 days: May increase to target dose of 300 mg once daily 1
- Take in morning to minimize insomnia risk 7
- Swallow whole; do not crush, divide, or chew 1
Dose adjustments required for:
- Moderate-severe hepatic impairment: Maximum 150 mg every other day 1
- Renal impairment (GFR <90 mL/min): Consider dose/frequency reduction 1
Common Pitfalls to Avoid
- Do not prescribe bupropion for adjustment disorder simply because depressed mood is present - the diagnosis matters for treatment selection
- Do not overlook psychotherapy - it should be offered first for adjustment disorders
- Do not ignore seizure risk factors - carefully screen history before prescribing
- Do not combine with MAOIs - requires 14-day washout period 1
- Do not assume bupropion is anxiolytic - it may initially worsen anxiety symptoms in some patients 10
Bottom Line
For true adjustment disorder with depressed mood, psychotherapy is the evidence-based first-line treatment. If symptoms are severe enough to warrant antidepressant medication, this suggests the clinical picture may actually represent MDD rather than adjustment disorder, and diagnosis should be reassessed. In that case, bupropion is a reasonable option among second-generation antidepressants, particularly when targeting specific symptom profiles (low energy, sexual dysfunction concerns, smoking cessation) or when SSRIs are contraindicated or poorly tolerated.